Douglas Braaten

2.1k citations
21 papers · 1.8k indexed · h-index 16
Topics
HIV Research and Treatment (8 papers)Signaling Pathways in Disease (7 papers)Viral-associated cancers and disorders (6 papers)
Partner nations
United StatesItalyCanada

In The Last Decade

Douglas Braaten

21 papers receiving 1.8k citations

Peers

Douglas Braaten
Comparison fields: 5 of 76
  • Molecular Biology 1.1k
  • Virology 1.0k
  • Immunology 538
  • Infectious Diseases 501
  • Epidemiology 372
Replace Reinhold Welker with:
Reinhold Welker Germany
Uwe Tessmer Germany
J W Dubay United States
Lily I. Wu United States
Valerie Bosch Germany
Bettina Strack United States
Heather L. Wiegand United States
Lori V. Coren United States
E K Franke United States
Adam J. Fletcher United Kingdom
Douglas Braaten relative to Reinhold Welker Germany Reinhold Welker's profile →
Citations per field
00.5×1.5×
Reinhold Welker · 1×
Citations per year

Countries citing papers authored by Douglas Braaten

Since Specialization
Citations

This map shows the geographic impact of Douglas Braaten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Braaten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Braaten more than expected).

Fields of papers citing papers by Douglas Braaten

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Braaten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Braaten. The network helps show where Douglas Braaten may publish in the future.

Co-authorship network of co-authors of Douglas Braaten

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Braaten. A scholar is included among the top collaborators of Douglas Braaten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Braaten. Douglas Braaten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 5
3 1
4 21
5 44
6 62
7 47
8 90
9 235
10 80
11 86
12 9
13 146
14 131
15 336
16 87
17 17
18 59
19 24
20 14

About Douglas Braaten

Douglas Braaten is a scholar working on Virology, Immunology and Oncology, having authored 21 papers that have together received 1.8k indexed citations. Recurring topics across this work include HIV Research and Treatment (8 papers), Signaling Pathways in Disease (7 papers) and Viral-associated cancers and disorders (6 papers). The work is most often cited by research in Virology (1.0k citations), Infectious Diseases (501 citations) and Immunology (538 citations). Douglas Braaten has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Jeremy Luban, E K Franke, Fabio Re, Randall D. Little, Herbert W. Virgin, Samuel H. Speck, W Phares, Claudia Aberham, Liang Yin and David Schlessinger. Their work appears in journals such as Nucleic Acids Research, Nature Medicine and The EMBO Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026